1.32

5.04% -0.07

After Hours: 1.33 0.01 +0.76%

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $1.32, with a volume of 1.42M. It is down -5.04% in the last 24 hours and down -14.29% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$1.39

Open:

$1.38

24h Volume:

1.42M

Relative Volume:

0.94

Market Cap:

$389.64M

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

-3.3846

EPS:

-0.39

Net Cash Flow:

$-68.47M

1W Performance:

-3.65%

1M Performance:

-14.29%

6M Performance:

+41.62%

1Y Performance:

-0.75%

1-Day Range:

$1.28

$1.39

1-Week Range:

$1.28

$1.47

52-Week Range:

$0.6513

$2.17

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1170)

Industry

Biotechnology (667)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2025-03-19

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	1.32	404.40M	6.23M	-95.90M	-68.47M	-0.39
ONC Beone Medicines Ltd Adr	245.58	26.10B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	442.05	111.96B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.35	42.96M	0	0	0	0.00
VRNA Verona Pharma Plc Adr	81.20	6.39B	0	-153.72M	-103.81M	-2.00
REGN Regeneron Pharmaceuticals Inc	490.28	63.52B	14.09B	4.50B	2.96B	39.28

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

May 31, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World

May 31, 2025

May 28, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World

May 28, 2025

May 26, 2025

D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 26, 2025

May 24, 2025

Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 24, 2025

May 20, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025

May 17, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World

May 17, 2025

May 16, 2025

Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 16, 2025

Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 16, 2025

May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa

May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus

May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus

May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria

May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia

May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com

May 15, 2025

May 14, 2025

Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025